36 related articles for article (PubMed ID: 3855433)
1. Efficacy and toxicity of plasma-cell-reactive monoclonal antibodies B-B2 and B-B4 and their immunotoxins.
Vooijs WC; Post J; Wijdenes J; Schuurman HJ; Bolognesi A; Polito L; Stirpe F; Bast EJ; de Gast GC
Cancer Immunol Immunother; 1996 Jul; 42(6):319-28. PubMed ID: 8830734
[TBL] [Abstract][Full Text] [Related]
2. Different cytotoxic activity and intracellular fate of an anti-CD5-momordin immunotoxin in normal compared to tumour cells.
Porro G; Lento P; Marcucci F; Gromo G; Modena D
Cancer Immunol Immunother; 1995 Apr; 40(4):213-8. PubMed ID: 7538448
[TBL] [Abstract][Full Text] [Related]
3. Inserting EF1α-driven CD7-specific CAR at CD7 locus reduces fratricide and enhances tumor rejection.
Jiang J; Chen J; Liao C; Duan Y; Wang Y; Shang K; Huang Y; Tang Y; Gao X; Gu Y; Sun J
Leukemia; 2023 Aug; 37(8):1660-1670. PubMed ID: 37391486
[TBL] [Abstract][Full Text] [Related]
4. Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape Enhancers.
Fuchs H; Weng A; Gilabert-Oriol R
Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27376327
[TBL] [Abstract][Full Text] [Related]
5. Chemical construction of immunotoxins.
Ghetie V; Vitetta ES
Mol Biotechnol; 2001 Jul; 18(3):251-68. PubMed ID: 11503519
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies--therapeutic and diagnostic uses in malignancy.
Lowder JN; Levy R
West J Med; 1985 Dec; 143(6):810-8. PubMed ID: 3911594
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo elimination of neoplastic T-cells from human marrow using an anti-Mr 41,000 protein immunotoxin: potentiation by ASTA Z 7557.
Uckun FM; Ramakrishnan S; Houston LL
Blut; 1985 Jan; 50(1):19-23. PubMed ID: 3881146
[TBL] [Abstract][Full Text] [Related]
8. Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.
Ford CH; Casson AG
Cancer Chemother Pharmacol; 1986; 17(3):197-208. PubMed ID: 3527466
[TBL] [Abstract][Full Text] [Related]
9. Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia.
Uckun FM; Gajl-Peczalska KJ; Kersey JH; Houston LL; Vallera DA
J Exp Med; 1986 Feb; 163(2):347-68. PubMed ID: 3511171
[TBL] [Abstract][Full Text] [Related]
10. An immunotoxin containing a rat IgM monoclonal antibody (Campath 1) and saporin 6: effect on T lymphocytes and hemopoietic cells.
Tazzari PL; Barbieri L; Gobbi M; Dinota A; Rizzi S; Bontadini A; Pession A; Tura S; Stirpe F
Cancer Immunol Immunother; 1988; 26(3):231-6. PubMed ID: 3260131
[TBL] [Abstract][Full Text] [Related]
11. An immunotoxin containing momordin suitable for bone marrow purging in multiple myeloma patients.
Dinota A; Barbieri L; Gobbi M; Tazzari PL; Rizzi S; Bontadini A; Bolognesi A; Tura S; Stirpe F
Br J Cancer; 1989 Sep; 60(3):315-9. PubMed ID: 2789938
[TBL] [Abstract][Full Text] [Related]
12. In vitro synergism between hybrid immunotoxins and chemotherapeutic drugs: relevance to immunotherapy of prostate carcinoma.
Webb KS; Liberman SN; Ware JL; Walther PJ
Cancer Immunol Immunother; 1986; 21(2):100-6. PubMed ID: 2418949
[TBL] [Abstract][Full Text] [Related]
13. Increased efficiency in selective elimination of leukemia cells by a combination of a stable derivative of cyclophosphamide and a human B-cell-specific immunotoxin containing pokeweed antiviral protein.
Uckun FM; Ramakrishnan S; Houston LL
Cancer Res; 1985 Jan; 45(1):69-75. PubMed ID: 3871174
[TBL] [Abstract][Full Text] [Related]
14. Anti-T cell immunotoxins containing pokeweed anti-viral protein: potential purging agents for human autologous bone marrow transplantation.
Ramakrishnan S; Uckun FM; Houston LL
J Immunol; 1985 Nov; 135(5):3616-22. PubMed ID: 3900212
[TBL] [Abstract][Full Text] [Related]
15. Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin.
Montgomery RB; Kurtzberg J; Rhinehardt-Clark A; Haleen A; Ramakrishnan S; Olsen GA; Peters WP; Smith CA; Haynes BF; Houston LL
Bone Marrow Transplant; 1990 Jun; 5(6):395-402. PubMed ID: 2369680
[TBL] [Abstract][Full Text] [Related]
16. Growth of permanent lymphoid cell cultures from human source: tenth anniversary.
Wang CH; Sinkovics JG; Kay HD; Györkey F; Shullenberger CC
Tex Rep Biol Med; 1975; 33(1):213-50. PubMed ID: 171791
[TBL] [Abstract][Full Text] [Related]
17. Large scale manufacturing of TXU(anti-CD7)-pokeweed antiviral protein (PAP) immunoconjugate for clinical trials.
Myers DE; Jun X; Clementson D; Donelson R; Sicheneder A; Hoffman N; Bell K; Sarquis M; Langlie MC; Turner N; Uckun FM
Leuk Lymphoma; 1997 Oct; 27(3-4):275-302. PubMed ID: 9402326
[TBL] [Abstract][Full Text] [Related]
18. Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow.
Uckun FM; Ramakrishnan S; Houston LL
J Immunol; 1985 Mar; 134(3):2010-6. PubMed ID: 3855433
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
